missing translation for 'onlineSavingsMsg'
Learn More

CD43/Sialophorin Antibody (DF-T1), Novus Biologicals™

Mouse Monoclonal Antibody

£232.00 - £462.00

Specifications

Antigen CD43/Sialophorin
Clone DF-T1
Concentration 0.2mg/mL
Dilution Western Blot 0.5-1ug/ml, Flow Cytometry 0.5-1ug/million cells, ELISA 1-5ug/ml for coating, Immunocytochemistry/Immunofluorescence 1-2ug/ml, Immunoprecipitation 1-2ug/500ug protein lysate, Immunohistochemistry-Paraffin 0.5-1ug/ml, Immunohistochemistry-Frozen 0.5-1ug/ml
Classification Monoclonal
View More Specs

Products 3
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18198223
View Documents
Novus Biologicals
NBP2-15190-0.1MG
0.1 mg
£392.00
0.10mg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
18191644
View Documents
Novus Biologicals
NBP2-15190-0.2MG
0.2 mg
£462.00
0.20mg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
18449871
View Documents
Novus Biologicals
NBP2-15190-20ug
20 ug
£232.00
20µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

CD43/Sialophorin Monoclonal specifically detects CD43/Sialophorin in Human samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.
Specifications

Specifications

CD43/Sialophorin
0.2mg/mL
Monoclonal
Purified
RUO
PBS with 0.05% BSA. with 0.05% Sodium Azide
CD43 antigen, CD43), Galactoglycoprotein, GALGP, Leukocyte sialoglycoprotein, Sialophorin, sialophorin (gpL115, leukosialin, CD43)
SPN
IgG1 κ
Protein G purified
It recognizes a cell surface glycoprotein of 95/115/135kDa (depending upon the extent of glycosylation), identified as CD43. 70-90% of T-cell lymphomas and from 22-37% of B-cell lymphomas express CD43. No reactivity has been observed with reactive B-cells. So a B-lineage population that co-expresses CD43 is highly likely to be a malignant lymphoma, especially a low-grade lymphoma, rather than a reactive B-cell population. When CD43 antibody is used in combination with anti-CD20, effective immunophenotyping of the lymphomas in formalin-fixed tissues can be obtained. Co-staining of a lymphoid infiltrate with anti-CD20 and anti-CD43 argues against a reactive process and favors a diagnosis of lymphoma.
DF-T1
Western Blot 0.5-1ug/ml, Flow Cytometry 0.5-1ug/million cells, ELISA 1-5ug/ml for coating, Immunocytochemistry/Immunofluorescence 1-2ug/ml, Immunoprecipitation 1-2ug/500ug protein lysate, Immunohistochemistry-Paraffin 0.5-1ug/ml, Immunohistochemistry-Frozen 0.5-1ug/ml
Unconjugated
Mouse
B Cell Development and Differentiation Markers, Immunology
P16150
6693
Myeloblastic KG1 cells were used as the immunogen for this antibody.
Primary
Store at 4C.
Videos
SDS
Documents

Documents

Product Certifications

For Research Use Only

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.